1.1. Wolfe, E. L., Guydish, J., Woods, W., & Tajima, B. (2004). Perspectives on the drug court model across systems: A process evaluation[dagger]. Journal of Psychoactive Drugs, 36(3), 379-386.
1.2. Davis, W. N. (2003). Special problems for specialty courts. ABA Journal, 89, 32-38.
2. Positive of Drug Courts
2.1. Carey, S. M., Finigan, M., Crumpton, D., & Waller, M. (2006). California drug courts: Outcomes, costs and promising practices: An overview of phase II in a statewide study[dagger]. Journal of Psychoactive Drugs, , 345-356.
2.2. Wolfe, E. L., Guydish, J., Woods, W., & Tajima, B. (2004). Perspectives on the drug court model across systems: A process evaluation[dagger]. Journal of Psychoactive Drugs, 36(3), 379-386.
2.3. Banks, D., & Gottfredson, D. C. (2004). Participation in drug treatment court and time to rearrest. Justice Quarterly,21(3), 637-658.
2.4. Goldkamp, J. S. (2003). The impact of drug courts. Criminology & Public Policy, 2(2), 197-205.
2.5. Richert, D. (2008). Drug court expansion could save billions. Judicature, 92(2), 91.
3. Conclusions
3.1. Here I will state my own personal opinion and recommendation for the use of Drug courts going forward.
4. History of Drug Courts
4.1. Wolfe, E. L., Guydish, J., Woods, W., & Tajima, B. (2004). Perspectives on the drug court model across systems: A process evaluation[dagger]. Journal of Psychoactive Drugs, 36(3), 379-386.
